Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-11-25

Clinical Trial Update: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

View source ↗

Summary

Clinical trial update examining the prevalence of cytomegalovirus, Epstein-Barr virus, and HHV-6 in the saliva of a patient with periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Cytomegalovirus, Epstein-Barr Virus Infections | Status: UNKNOWN